摘要
目的观察分析帕罗西汀联合百乐眠治疗脑卒中睡眠障碍患者的临床疗效,并观察其对患者睡眠质量的影响。方法选择我院2016年1月—2017年3月收治的124例脑卒中睡眠障碍患者,随机分为对照组和联合组,每组62例,对照组采用帕罗西汀进行治疗,联合组在对照组治疗措施的基础上加用百乐眠进行治疗,比较两组患者的临床疗效以及治疗前后睡眠质量指数变化。结果联合组临床总有效率为93.55%(58/62),高于对照组的79.03%(49/62),差异有统计学意义(P<0.05);联合组治疗后睡眠质量指数较治疗前以及对照组治疗后均明显降低,差异有统计学意义(P<0.05)。结论联合应用帕罗西汀与百乐眠治疗脑卒中睡眠障碍患者可以显著的提高睡眠质量,取得显著的临床疗效。
Objective To observe and analyze the clinical efficacy of paroxetine combined with Bailemian in the treatment of stroke patients with sleep disorder,and to observe the influence on sleep quality of the patients.Methods124patients with stroke sleep disorders from January2016to March2017in our hospital were randomly divided into control group and combination group,62cases in each group,the control group was treated by paroxetine,the combination group based on the control group treatment was treated with Bailemian,two groups of patients with clinical efficacy and sleep quality index changes before and after treatment were compared.Results The clinical total effective rate in combination group was93.55%(58/62),significantly higher than79.03%(49/62)in the control group,the difference was statistically significant(P<0.05).The sleep quality index of the combined group was better than that before treatment and the control group after treatment,the difference was statistically significant(P<0.05).Conclusion Combined use of paroxetine and Bailemian in patients with stroke sleep disorders can significantly improve the quality of sleep,and achieve significant clinical efficacy.
作者
蔡利颖
丁金环
CAI Liying;DING Jinhuan(Department of Neurology, FAW General Hospital, Changchun Jilin 130011, China)
出处
《中国卫生标准管理》
2017年第16期100-101,共2页
China Health Standard Management
